Design and Optimization of Rivaroxaban-Cyclodextrin-Polymer Triple Complex Formulation with Improved Solubility.

Kang, Ji-Hyun; Lee, Ji-Eun; Jeong, So-Jeong; Park, Chun-Woong; Kim, Dong-Wook; Weon, Kwon-Yeon

Kang, Ji-Hyun; Lee, Ji-Eun; Jeong, So-Jeong; Park, Chun-Woong; Kim, Dong-Wook; Weon, Kwon-Yeon.

Affiliation

Kang JH; College of Pharmacy, Chungbuk National University, Cheongju, Korea.
Lee JE; College of Pharmacy, Chungbuk National University, Cheongju, Korea.
Jeong SJ; College of Pharmacy, Chungbuk National University, Cheongju, Korea.
Park CW; College of Pharmacy, Chungbuk National University, Cheongju, Korea.
Kim DW; College of Pharmacy, Wonkwang University, Iksan, Korea.
Weon KY; College of Pharmacy, Daegu Catholic University, Gyeongsan, Korea.

Drug Des Devel Ther ; 16: 4279-4289, 2022.

Article de En | MEDLINE | ID: mdl-36561308

Sujet(s)
Mots clés

design of experiment; drug-cyclodextrin-polymer triple complex; rivaroxaban; solubilization

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Cyclodextrines / Rivaroxaban Limites: Humans Langue: En Journal: Drug Des Devel Ther Sujet du journal: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Année: 2022 Type de document: Article Pays de publication: Nouvelle-Zélande

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google